Cite
Insight into the preclinical studies of phytomedicines in cancer theragnostics.
MLA
Kumar, Akash, et al. “Insight into the Preclinical Studies of Phytomedicines in Cancer Theragnostics.” Minerva Biotechnology & Biomolecular Research, vol. 35, no. 3, Sept. 2023, pp. 173–91. EBSCOhost, https://doi.org/10.23736/S2724-542X.23.02968-1.
APA
Kumar, A., Pramanik, J., Rustagi, S., Bharti, S., Trehan, A., Katyal, M., Thakur, S., Haque, S., Bora, J., Kishore, S., & Malik, S. (2023). Insight into the preclinical studies of phytomedicines in cancer theragnostics. Minerva Biotechnology & Biomolecular Research, 35(3), 173–191. https://doi.org/10.23736/S2724-542X.23.02968-1
Chicago
Kumar, Akash, Jhilam Pramanik, Sarvesh Rustagi, Sweety Bharti, Anchal Trehan, Mehak Katyal, Sheetal Thakur, et al. 2023. “Insight into the Preclinical Studies of Phytomedicines in Cancer Theragnostics.” Minerva Biotechnology & Biomolecular Research 35 (3): 173–91. doi:10.23736/S2724-542X.23.02968-1.